22nd MEET THE PROFESSOR

Advanced International
Breast Cancer Course

Padova | September 17–18, 2026

Breast cancer research has been the frontrunner in many fields of cancer research: epidemiology, life-style and genetic risk factors, secondary prevention, conservative surgery, molecular classification, curative adjuvant therapies, neoadjuvant treatments, targeted agents, survival prolongation in advanced stages. Thanks to this knowledge, today many breast cancers can be prevented, most can be diagnosed at early stages and cured and the minority of patients at advanced stages can still enjoy a significant survival with a reasonable quality of life.
As a consequence of these major improvements, the bar of research and clinical excellence for breast cancer has raised even more.
New prognostic and predictive biomarkers are available, need to be validated and to be implemented in trial design and clinical practice. Risk-adapted surgery and radiation therapy allow for less and less invasive procedures. Multiple effective adjuvant therapies in the different molecular breast cancer subtypes, require a more precise definition of risk and predictivity of drug efficacy, to allow for a rational de-escalation or escalation of curative treatments. The impressive advances in the treatment of advanced breast cancers, envisage the possibility of cure with a multimodality approach for some patients and guarantee a prolonged survival for most of them with a rational sequencing of treatments.
The 22nd AIBCC in Padova, will allow to sum up the most recent biological and clinical achievements and to allow an open and friendly discussion of clinical cases among key opinion leaders and participants.

Addressed to
Gynaecologists and obstetrics, medical oncologists, pathologists, radiologists, radiation oncologists, surgeons. Pharmacists.

Faculty Insights

Scientific Program

Thursday, September 17th

10.30	Introduction to the Conference Pierfranco Conte, Valentina Guarneri, Philip Poortmans, Aleix Prat
10.45	ESMO President Elect – Welcome Remark Giuseppe Curigliano

SESSION I – HR+/HER2- Chairpersons: Giuseppe Curigliano, Valentina Guarneri, Jacek Jassem

11.00	Clinical and biological definition of early and late risk of relapseCarmine De Angelis
11.20	Navigating adjuvant ET optionsStephen Johnston
11.40	Opportunities for radiation therapy de-escalationPhilip Poortmans
12.00	Exploiting endocrine resistance in advanced diseaseGaia Griguolo
12.20	Revisited metastatic algorithmPeter Fasching
12.40	Discussion
13.20	Lunch

SESSION II – HER2+ Chairpersons: Pierfranco Conte, Lucia Del Mastro, Hesham A.G. Elghazaly

14.20	Turning biological heterogeneity into clinical actionAleix Prat
14.40	Treatment escalation: neoadjuvant vs post-neoadjuvant strategiesSibylle Loibl
15.00	Redefining 1st line for advanced disease: induction CT vs ADC? Duration? Which maintenance?Sandra Swain
15.20	Discussion
15.40	Clinical Multidisciplinary Shooting Session 1 – HR+/HER2- and HER2+Panelists: Pierfranco Conte, Carmine De Angelis, Lucia Del Mastro, Hesham A.G. Elghazaly, Peter Fasching, Gaia Griguolo, Valentina Guarneri, Jacek Jassem, Sibylle Loibl, Stephen Johnston, Philip Poortmans, Aleix Prat, Tanja Spanic, Sandra Swain · Shooter: Michele Bottosso
17.00	Ceremony for the presentation of the University of Padua Award for Advances in Breast Cancer 2026
17.15	Lecture of the Awardee
18.00	Adjourn

Friday, September 18th

SESSION III – TNBC Chairpersons: Valentina Guarneri, Aleix Prat, Fabio Puglisi

9.00	Markers of sensitivity/resistance to immunotherapyMaria Vittoria Dieci
9.20	Balancing escalation and de-escalation in eTNBCHope Rugo
9.40	1st line PD-L1+: ADC + ICI for all?Mario Giuliano
10.00	Discussion
10.20	Coffee break

SESSION IV – ROUND TABLE DISCUSSION: FOCUS ON YOUNG WOMEN Chairpersons: Sibylle Loibl, Fedro A. Peccatori

10.50	Fertility and pregnancy · Hereditary syndromes · Surgical managementMatteo Lambertini · Banu Arun · Eleftherios Mamounas
12.00	Discussion
12.30	Lunch

SESSION V – HOT TOPICS Chairpersons: Bettina Borisch, Michelino De Laurentiis, Sandra Swain

13.30	Clinical implications of liquid biopsy: MRD, monitoring, guide for target treatmentLuca Malorni
13.50	AI applied to histopathologyFrederique Penault-Llorca
14.10	Dealing with new patterns of toxicityFederica Miglietta
14.30	The right to be forgotten: Ending Discrimination Against Cancer SurvivorsGrazia Scocca
14.50	Discussion
15.20	Clinical Multidisciplinary Shooting Session 2 – TNBC and special situationsPanelists: Banu Arun, Bettina Borisch, Michelino De Laurentiis, Maria Vittoria Dieci, Mario Giuliano, Matteo Lambertini, Sibylle Loibl, Luca Malorni, Eleftherios Mamounas, Federica Miglietta, Fedro A. Peccatori, Frederique Penault-Llorca, Aleix Prat, Fabio Puglisi, Hope Rugo, Sandra Swain · Shooter: Davide Massa
16.40	Take home messages and adjournPierfranco Conte, Valentina Guarneri, Aleix Prat, Philip Poortmans

CME

Based on the in force regulations approved by the CNFC, Accademia Nazionale di Medicina (provider n. 31) will assign to the activity CME: 11 CME points.

Training objective: professional and technical content (knowledge and skills) specific to each profession, specialisation and highly specialised activity. Rare disease.

To obtain CME credits, participants must meet the following requirements:

Their declared profession/specialization must correspond to those accredited for CME.
They must attend at least 90% of the course.
They must complete the online meeting evaluation form.
They must pass the learning assessment test with at least 75% correct answers. Only one attempt is allowed.

The learning assessment test and meeting evaluation form must be submitted within three days of the event.

Official Language

The official language of the Meeting is English. No simultaneous translation will be provided.

Registration

Online registration at fad.accmed.org before September 5th; the application will be completed only after the payment of the registration fee:

€ 120,00
€ 80,00 for graduate students
€ 80,00 for AIOM members

Cancellation and Refunds

In order to cancel please give advice with a written communication to Accademia Nazionale di Medicina within 10 days from the beginning. A 70% of the registration fee will be returned. Any cancellation after that deadline will not be reimbursed.

Awards & Fellowships

University of Padova Award for Advances in Breast Cancer 2026

The Scientific Committee will select a young researcher working in Europe (≤ 40 years old, oncologists, radiation oncologists, pathologists). Candidates will be asked to submit a publication where they are the lead author, published in 2025–2026, along with a CV.

For application, the candidates have to send their CV and chosen publication 2025–2026, by July 30th, 2026 to info.bologna@accmed.org.

The winner will be invited to present his study at the AIBCC (with travel and accommodation expenses covered).

Fellowships

Some fellowships will be awarded including registration, 1 hotel night and travel organization (max € 200,00). For application: info.bologna@accmed.org by July 30th.

The organizing secretariat will confirm the award of the fellowship by August 5th and proceed with the organization of logistics.

Under 40

Free registration available. Availability is limited. For application: info.bologna@accmed.org by July 30th.

Faculty

Directors

Pierfranco Conte

Venezia (IT)

Scientific Director S. Camillo Hospital, IRCCS, Venezia (IT)

Valentina Guarneri

Padova (IT)

Division of Medical Oncology 2, Istituto Oncologico Veneto IRCCS, Department of Surgery, Oncology and Gastroenterology, University of Padova (IT)

Philip Poortmans

Wilrijk-Antwerp (BE)

Former president of ESTRO and of ECCO, Department of Radiation Oncology, Iridium Netwerk, University of Antwerp (BE)

Aleix Prat

Barcelona (ES)

Clinic Barcelona Comprehensive Cancer Center, University of Barcelona – Barcelona (ES)

Scientific Committee

Bettina Borisch Institute of Global Health – Geneve (CH)

Maria Vittoria Dieci Division of Medical Oncology 2, Istituto Oncologico Veneto IRCCS, Dept. of Surgery, Oncology and Gastroenterology – Padova (IT)

Hesham A. G. Elghazaly Dept. of Clinical Oncology and Nuclear Medicine, University of Ainshams – Cairo (EG)

Jacek Jassem Dept. of Oncology and Radiotherapy, Medical University of Gdansk (PL)

Stephen Johnston NIHR Biomedical Research Centre for Cancer, Royal Marsden NHS Foundation Trust & Institute of Cancer Research – London (UK)

Sibylle Loibl German Breast Group, University of Frankfurt (DE)

Eleftherios Mamounas Comprehensive Breast Program, MD Anderson Cancer Center Orlando – Orlando (US)

Fedro Alessandro Peccatori Dept. of Medical Oncology, European Institute of Oncology (IEO) – Milano (IT)

Sandra M. Swain Professor of Medicine, Associate Dean Research Development, Georgetown University Medical Center – Washington (US)

Invited Speakers & Chairpersons

Banu Arun Department of Breast Medical Oncology, Division of Cancer Medicine – MD Anderson Cancer Center – Houston (USA)

Michele Bottosso Division of Medical Oncology 2, Istituto Oncologico Veneto IRCCS, Dept. of Surgery, Oncology and Gastroenterology – University of Padova (IT)

Giuseppe Curigliano Department of Oncology – European Institute of Oncology – University of Milano (IT)

Carmine De Angelis Scuola Superiore Meridionale – Clinical and Translational Oncology – CTO – Napoli (IT)

Michelino De Laurentiis Breast Unit – Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale" – Napoli (IT)

Lucia Del Mastro Division of Medical Oncology – IRCCS Ospedale Policlinico San Martino – Genova (IT)

Peter Fasching University Hospital Erlangen and Comprehensive Cancer Center – Erlangen (DE)

Mario Giuliano U.O. Oncologia Medica – Università degli Studi "Federico II" – Napoli (IT)

Gaia Griguolo Division of Medical Oncology 2, Istituto Oncologico Veneto IRCCS, Dept. of Surgery, Oncology and Gastroenterology – University of Padova (IT)

Matteo Lambertini Breast Unit – IRCCS Ospedale Policlinico San Martino – Genova (IT)

Luca Malorni Division of Oncology – Azienda USL Toscana Centro, Nuovo Ospedale di Prato Santo Stefano – Prato (IT)

Davide Massa Division of Medical Oncology 2, Istituto Oncologico Veneto IRCCS, Dept. of Surgery, Oncology and Gastroenterology – University of Padova (IT)

Federica Miglietta Division of Medical Oncology 2, Istituto Oncologico Veneto IRCCS, Dept. of Surgery, Oncology and Gastroenterology – University of Padova (IT)

Frederique Penault-Llorca Centre Jean Perrin, University – Clermont Ferrand (FR)

Fabio Puglisi Department of Medical Oncology – Centro di Riferimento Oncologico (CRO), IRCCS, Aviano – Department of Medicine, University of Udine (IT)

Hope Rugo Breast Oncology Clinical Trials Program – UCSF Carol Franc Buck Breast Care Center – San Francisco (USA)

Grazia Scocca Institute for European Studies – Bruxelles (BE)

Tanja Spanic Europa Donna Slovenia – The European Breast Cancer Coalition Europa Donna – Ljubljana (SLO)

Meeting Venue

Palazzo della Salute

Via San Francesco, 90 – Padua

The Center is located in the ZTL area. We recommend the Interparking Italia – Via Trieste 50.

Open in Google Maps

Advanced InternationalBreast Cancer Course